Something else you don't know much about. I'll go back to what I've previously stated about DMT. It's the story that matters NOT the results. Compass Pathways and Mind|Med has increased their market caps by hundreds of millions just because of their Psychedelic stories not clinical trial results. I could care less about still being here through whatever phases of DMT clinical trials. Just get the story out there and get folks onboard. It's all about the messaging of DMT - The New Frontier. That's what's of significant value at the micro cap level, but you simply can't see that part of the equation.
Let me ask you something...Are you aware of the Cannabix Technologies story?
What do you think has driven that companies share price from 3 cent to 3 dollars to 30 cent to 2 dollars and yada yada yada?
News 
Market Data 
Discover 
